Current Therapeutic Strategies and Possible Effective Drug Delivery Strategies against COVID-19

National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Human coronavirus types. 2020. Available from: https://www.cdc.gov/coronavirus/types.html

de Groot, R.J.; Baker, S.C.; Baric, R.S.; Brown, C.S.; Drosten, C.; Enjuanes, L.; Fouchier, R.A.M.; Galiano, M.; Gorbalenya, A.E.; Memish, Z.A.; Perlman, S.; Poon, L.L.M.; Snijder, E.J.; Stephens, G.M.; Woo, P.C.Y.; Zaki, A.M.; Zambon, M.; Ziebuhr, J. Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J. Virol., 2013, 87(14), 7790-7792.
[http://dx.doi.org/10.1128/JVI.01244-13] [PMID: 23678167]

Pollett, S.; Conte, M.A.; Sanborn, M.; Jarman, R.G.; Lidl, G.M.; Modjarrad, K.; Maljkovic Berry, I. A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic. Sci. Rep., 2021, 11(1), 17365.
[http://dx.doi.org/10.1038/s41598-021-96626-8] [PMID: 34462471]

Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol., 2020, 94(7), e00127-20.
[http://dx.doi.org/10.1128/JVI.00127-20] [PMID: 31996437]

Jeffers, S.A.; Tusell, S.M.; Gillim-Ross, L.; Hemmila, E.M.; Achenbach, J.E.; Babcock, G.J.; Thomas, W.D., Jr; Thackray, L.B.; Young, M.D.; Mason, R.J.; Ambrosino, D.M.; Wentworth, D.E.; DeMartini, J.C.; Holmes, K.V. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA, 2004, 101(44), 15748-15753.
[http://dx.doi.org/10.1073/pnas.0403812101] [PMID: 15496474]

Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N.H.; Nitsche, A.; Müller, M.A.; Drosten, C.; Pöhlmann, S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020, 181(2), 271-280.e8.
[http://dx.doi.org/10.1016/j.cell.2020.02.052] [PMID: 32142651]

Blaess, M.; Kaiser, L.; Sauer, M.; Csuk, R.; Deigner, H.P. COVID-19/SARS-CoV-2 infection: Lysosomes and lysosomotropism implicate new treatment strategies and personal risks. Int. J. Mol. Sci., 2020, 21(14), 4953.
[http://dx.doi.org/10.3390/ijms21144953] [PMID: 32668803]

Yang, N.; Shen, H.M. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int. J. Biol. Sci., 2020, 16(10), 1724-1731.
[http://dx.doi.org/10.7150/ijbs.45498] [PMID: 32226290]

Ballout, R.A.; Sviridov, D.; Bukrinsky, M.I.; Remaley, A.T. The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications. FASEB J., 2020, 34(6), 7253-7264.
[http://dx.doi.org/10.1096/fj.202000654R] [PMID: 32367579]

Shang, J.; Wan, Y.; Luo, C.; Ye, G.; Geng, Q.; Auerbach, A.; Li, F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA, 2020, 117(21), 11727-11734.
[http://dx.doi.org/10.1073/pnas.2003138117] [PMID: 32376634]

Heald-Sargent, T.; Gallagher, T. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses, 2012, 4(4), 557-580.
[http://dx.doi.org/10.3390/v4040557] [PMID: 22590686]

Belouzard, S.; Millet, J.K.; Licitra, B.N.; Whittaker, G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 2012, 4(6), 1011-1033.
[http://dx.doi.org/10.3390/v4061011] [PMID: 22816037]

Kawase, M.; Shirato, K.; van der Hoek, L.; Taguchi, F.; Matsuyama, S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol., 2012, 86(12), 6537-6545.
[http://dx.doi.org/10.1128/JVI.00094-12] [PMID: 22496216]

Nakagawa, K.; Lokugamage, K.G.; Makino, S. Viral and cellular mRNA translation in coronavirus-infected cells. Adv. Virus Res., 2016, 96, 165-192.
[http://dx.doi.org/10.1016/bs.aivir.2016.08.001] [PMID: 27712623]

Wada, M.; Lokugamage, K.G.; Nakagawa, K.; Narayanan, K.; Makino, S. Interplay between coronavirus, a cytoplasmic RNA virus, and nonsense-mediated mRNA decay pathway. Proc. Natl. Acad. Sci. USA, 2018, 115(43), E10157-E10166.
[http://dx.doi.org/10.1073/pnas.1811675115] [PMID: 30297408]

Kikkert, M. Innate immune evasion by human respiratory RNA viruses. J. Innate Immun., 2020, 12(1), 4-20.
[http://dx.doi.org/10.1159/000503030] [PMID: 31610541]

Li, F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol., 2016, 3(1), 237-261.
[http://dx.doi.org/10.1146/annurev-virology-110615-042301] [PMID: 27578435]

Huang, Y.; Yang, C.; Xu, X.; Xu, W.; Liu, S. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol. Sin., 2020, 41(9), 1141-1149.
[http://dx.doi.org/10.1038/s41401-020-0485-4] [PMID: 32747721]

Zhang, C.; Wang, Y.; Zhu, Y.; Liu, C.; Gu, C.; Xu, S.; Wang, Y.; Zhou, Y.; Wang, Y.; Han, W.; Hong, X.; Yang, Y.; Zhang, X.; Wang, T.; Xu, C.; Hong, Q.; Wang, S.; Zhao, Q.; Qiao, W.; Zang, J.; Kong, L.; Wang, F.; Wang, H.; Qu, D.; Lavillette, D.; Tang, H.; Deng, Q.; Xie, Y.; Cong, Y.; Huang, Z. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat. Commun., 2021, 12(1), 264.
[http://dx.doi.org/10.1038/s41467-020-20465-w] [PMID: 33431876]

Zhang, L.; Jackson, C.B.; Mou, H.; Ojha, A.; Rangarajan, E.S.; Izard, T.; Farzan, M.; Choe, H. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv, 2020, 2020.2006.2012.148726.
[http://dx.doi.org/10.1101/2020.06.12.148726]

Zhang, L.; Jackson, C.B.; Mou, H.; Ojha, A.; Peng, H.; Quinlan, B.D.; Rangarajan, E.S.; Pan, A.; Vanderheiden, A.; Suthar, M.S.; Li, W.; Izard, T.; Rader, C.; Farzan, M.; Choe, H. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun., 2020, 11(1), 6013.
[http://dx.doi.org/10.1038/s41467-020-19808-4] [PMID: 33243994]

Mukherjee, S.; Liang, L.; Veiseh, O. Recent advancements of magnetic nanomaterials in cancer therapy. Pharmaceutics, 2020, 12(2), 147.
[http://dx.doi.org/10.3390/pharmaceutics12020147] [PMID: 32053995]

Cowman, K.; Guo, Y.; Liise-Anne, P.; Wong, D.; Bao, H.; Chen, V.; Hopkins, U.; Andrews, E.; Hamel, J.; Keller, M.; Bellin, E.; Thota, R.; Davis, P.; Rodriguez, E.T.; Suthar, P.; Allen, L.; Rossi, J.; Haviland, A.; Orner, E.; Szymczak, W.; Shujauddin, S.; McCarthy, J.; Binder, B.; Pushparaj, V.; Bard, L.; Pierino, V.F.; Alsina, L.; Esses, D.; McCaskie, A.; Campbell, C.; Madzura, T.; Wollowitz, A.; Basset, K.; White, De.; Ruiz, R.; Sosnowski, F.; Nori, P. Post-severe acute respiratory syndrome coronavirus 2 monoclonal antibody treatment hospitalizations as a sentinel for emergence of viral variants in New York City. Open Forum Infect. Dis., 2021, 8(8), ofab313.
[http://dx.doi.org/10.1093/ofid/ofab313]

Jangra, S.; Ye, C.; Rathnasinghe, R.; Stadlbauer, D.; Alshammary, H.; Amoako, A.A.; Awawda, M.H.; Beach, K.F.; Bermúdez-González, M.C.; Chernet, R.L.; Eaker, L.Q.; Ferreri, E.D.; Floda, D.L.; Gleason, C.R.; Kleiner, G.; Jurczyszak, D.; Matthews, J.C.; Mendez, W.A.; Mulder, L.C.F.; Russo, K.T.; Ashley-Beathrese, S.T.; Saksena, M.; Shin, A.S.; Sominsky, L.A.; Srivastava, K.; Krammer, F.; Simon, V.; Martinez-Sobrido, L.; García-Sastre, A.; Schotsaert, M. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe, 2021, 2(7), 283-284.
[http://dx.doi.org/10.1016/S2666-5247(21)00068-9]

Garcia-Beltran, W.F.; Lam, E.C.; St. Denis, K.; Nitido, A.D.; Garcia, Z.H.; Hauser, B.M.; Feldman, J.; Pavlovic, M.N.; Gregory, D.J.; Poznansky, M.C.; Sigal, A.; Schmidt, A.G.; John Iafrate, A.; Naranbhai, V.; Balazs, A.B. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell, 2021, 184(9), 2523.

Davies, N.G.; Abbott, S.; Barnard, R.C.; Jarvis, C.I.; Kucharski, A.J.; Munday, J.D.; Pearson, C.A.B.; Russell, T.W.; Tully, D.C.; Washburne, A.D.; Wenseleers, T.; Gimma, A.; Waites, W.; Wong, K.L.M.; van Zandvoort, K.; Silverman, J.D.; Diaz-Ordaz, K.; Keogh, R.; Eggo, R.M.; Funk, S.; Jit, M.; Atkins, K.E.; John Edmunds, W. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. medRxiv, 2021. 2020.2012.2024.20248822.
[http://dx.doi.org/10.1101/2020.12.24.20248822]

Wang, P.; Nair, M.S.; Liu, L.; Iketani, S.; Luo, Y.; Guo, Y.; Wang, M.; Yu, J.; Zhang, B.; Kwong, P.D.; Graham, B.S.; Mascola, J.R.; Chang, J.Y.; Yin, M.T.; Sobieszczyk, M.; Kyratsous, C.A.; Shapiro, L.; Sheng, Z.; Huang, Y.; Ho, D.D. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. bioRxiv, 2021, 2021.2001.2025.428137.
[http://dx.doi.org/10.21203/rs.3.rs-155394/v1]

Wu, K.; Werner, A.P.; Moliva, J.I.; Koch, M.; Choi, A.; Stewart-Jones, G.B.E.; Bennett, H.; Boyoglu-Barnum, S.; Shi, W.; Graham, B.S.; Carfi, A.; Corbett, K.S.; Seder, R.A.; Edwards, D.K. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv, 2021. 2021.2001. 2025.427948
[http://dx.doi.org/10.1101/2021.01.25.427948]

Xie, X.; Zou, J.; Fontes-Garfias, C.R.; Xia, H.; Swanson, K.A.; Cutler, M.; Cooper, D.; Menachery, V.D.; Weaver, S.; Dormitzer, P.R.; Shi, P-Y. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. bioRxiv, 2021. 2021.2001.2007. 425740
[http://dx.doi.org/10.1101/2021.01.07.425740]

Madhi, S.A.; Baillie, V.; Cutland, C.L.; Voysey, M.; Koen, A.L.; Fairlie, L.; Padayachee, S.D.; Dheda, K.; Barnabas, S.L.; Bhorat, Q.E.; Briner, C.; Kwatra, G.; Ahmed, K.; Aley, P.; Bhikha, S.; Bhiman, J.N.; As’ad, E.B.; du Plessis, J.; Esmail, A.; Groenewald, M.; Horne, E.; Hwa, S-H.; Jose, A.; Lambe, T.; Laubscher, M.; Malahleha, M.; Masenya, M.; Masilela, M.; McKenzie, S.; Molapo, K.; Moultrie, A.; Oelofse, S.; Patel, F.; Pillay, S.; Rhead, S.; Rodel, H.; Rossouw, L.; Taoushanis, C.; Tegally, H.; Thombrayil, A.; van Eck, S.; Wibmer, C.K.; Durham, N.M.; Kelly, E.J.; Villafana, T.L.; Gilbert, S.; Pollard, A.J.; de Oliveira, T.; Moore, P.L.; Sigal, A.; Izu, A. Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa. medRxiv, 2021, 2021.2002.2010.21251247.
[http://dx.doi.org/10.1101/2021.02.10.21251247]

Greaney, A.J.; Loes, A.N.; Crawford, K.H.D.; Starr, T.N.; Malone, K.D.; Chu, H.Y.; Bloom, J.D. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. bioRxiv, 2021, 2020.2012.2031.425021.
[http://dx.doi.org/10.1101/2020.12.31.425021]

Wang, P.; Casner, R.G.; Nair, M.S.; Wang, M.; Yu, J.; Cerutti, G.; Liu, L.; Kwong, P.D.; Huang, Y.; Shapiro, L.; Ho, D.D. Increased resistance of SARS-CoV-2 variant. bioRxiv, 2021. 2021.2003.2001. 433466

Al-Tawfiq, J.A.; Al-Homoud, A.H.; Memish, Z.A. Remdesivir as a possible therapeutic option for the COVID-19. Travel Med. Infect. Dis., 2020, 34, 101615.
[http://dx.doi.org/10.1016/j.tmaid.2020.101615] [PMID: 32145386]

Li, X.; Geng, M.; Peng, Y.; Meng, L.; Lu, S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal., 2020, 10(2), 102-108.
[http://dx.doi.org/10.1016/j.jpha.2020.03.001] [PMID: 32282863]

Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res., 2020, 30(3), 269-271.
[http://dx.doi.org/10.1038/s41422-020-0282-0] [PMID: 32020029]

Huentelman, M.J.; Zubcevic, J.; Hernández Prada, J.A.; Xiao, X.; Dimitrov, D.S.; Raizada, M.K.; Ostrov, D.A. Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. Hypertension, 2004, 44(6), 903-906.
[http://dx.doi.org/10.1161/01.HYP.0000146120.29648.36] [PMID: 15492138]

Zheng, Y.; Shang, J.; Yang, Y.; Liu, C.; Wan, Y.; Geng, Q.; Wang, M.; Baric, R.; Li, F. Lysosomal proteases are a determinant of coronavirus tropism. J. Virol., 2018, 92(24), e01504-18.
[http://dx.doi.org/10.1128/JVI.01504-18] [PMID: 30258004]

Vaduganathan, M.; Vardeny, O.; Michel, T.; McMurray, J.J.V.; Pfeffer, M.A.; Solomon, S.D. Renin–angiotensin–aldosterone system inhibitors in patients with covid-19. N. Engl. J. Med., 2020, 382(17), 1653-1659.
[http://dx.doi.org/10.1056/NEJMsr2005760] [PMID: 32227760]

Beigel, J.H.; Tomashek, K.M.; Dodd, L.E.; Mehta, A.K.; Zingman, B.S.; Kalil, A.C.; Hohmann, E.; Chu, H.Y.; Luetkemeyer, A.; Kline, S.; Lopez de Castilla, D.; Finberg, R.W.; Dierberg, K.; Tapson, V.; Hsieh, L.; Patterson, T.F.; Paredes, R.; Sweeney, D.A.; Short, W.R.; Touloumi, G.; Lye, D.C.; Ohmagari, N.; Oh, M.D.; Ruiz-Palacios, G.M.; Benfield, T.; Fätkenheuer, G.; Kortepeter, M.G.; Atmar, R.L.; Creech, C.B.; Lundgren, J.; Babiker, A.G.; Pett, S.; Neaton, J.D.; Burgess, T.H.; Bonnett, T.; Green, M.; Makowski, M.; Osinusi, A.; Nayak, S.; Lane, H.C. Remdesivir for the treatment of covid-19 - Preliminary report. N. Engl. J. Med., 2020.

De Savi, C.; Hughes, D.L.; Kvaerno, L. Quest for a COVID-19 cure by repurposing small-molecule drugs: Mechanism of action, clinical development, synthesis at scale, and outlook for supply. Org. Process Res. Dev., 2020, 24(6), 940-976.
[http://dx.doi.org/10.1021/acs.oprd.0c00233]

Spinner, C.D.; Gottlieb, R.L.; Criner, G.J.; Arribas López, J.R.; Cattelan, A.M.; Soriano Viladomiu, A.; Ogbuagu, O.; Malhotra, P.; Mullane, K.M.; Castagna, A.; Chai, L.Y.A.; Roestenberg, M.; Tsang, O.T.Y.; Bernasconi, E.; Le Turnier, P.; Chang, S.C.; SenGupta, D.; Hyland, R.H.; Osinusi, A.O.; Cao, H.; Blair, C.; Wang, H.; Gaggar, A.; Brainard, D.M.; McPhail, M.J.; Bhagani, S.; Ahn, M.Y.; Sanyal, A.J.; Huhn, G.; Marty, F.M. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19. JAMA, 2020, 324(11), 1048-1057.
[http://dx.doi.org/10.1001/jama.2020.16349] [PMID: 32821939]

Abd-Elsalam, S.; Ahmed, O.A.; Mansour, N.O.; Abdelaziz, D.H.; Salama, M.; Fouad, M.H.A.; Soliman, S.; Naguib, A.M.; Hantera, M.S.; Ibrahim, I.S.; Torky, M.; Dabbous, H.M.; El Ghafar, M.S.A.; Abdul-Baki, E.A.; Elhendawy, M. Remdesivir efficacy in COVID-19 treatment: A randomized controlled trial. Am. J. Trop. Med. Hyg., 2021, 106(3), 886-890.
[http://dx.doi.org/10.4269/ajtmh.21-0606] [PMID: 34649223]

Sleeman, K.; Mishin, V.P.; Deyde, V.M.; Furuta, Y.; Klimov, A.I.; Gubareva, L.V. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob. Agents Chemother., 2010, 54(6), 2517-2524.
[http://dx.doi.org/10.1128/AAC.01739-09] [PMID: 20350949]

Furuta, Y.; Komeno, T.; Nakamura, T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci., 2017, 93(7), 449-463.
[http://dx.doi.org/10.2183/pjab.93.027] [PMID: 28769016]

ClinicalTrials.gov. A study to evaluate the safety, pharmacokinetics and antiviral effects of galidesivir in yellow fever or COVID-19. 2020. Available from:https://clinicaltrials.gov/ct2/show/ NCT03891420 Retrieved 15th July 2020

BioCryst. BioCryst provides update on galidesivir program., 2020. Available from: https://ir.biocryst.com/news-releases/news-release-details/biocryst-provides-update-galidesivir-program Retrieved December 22, 2020.

de Wilde, A.H.; Jochmans, D.; Posthuma, C.C.; Zevenhoven-Dobbe, J.C.; van Nieuwkoop, S.; Bestebroer, T.M.; van den Hoogen, B.G.; Neyts, J.; Snijder, E.J. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob. Agents Chemother., 2014, 58(8), 4875-4884.
[http://dx.doi.org/10.1128/AAC.03011-14] [PMID: 24841269]

Kunz, K.M. A trial of lopinavir–ritonavir in covid-19. N. Engl. J. Med., 2020, 382(21), e68.
[http://dx.doi.org/10.1056/NEJMc2008043] [PMID: 32369282]

ClinicalTrials.gov. WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19., 2020. Available from: https://www.who.int/news-room/detail/04-07-2020-whodiscontinues- hydroxychloroquine-and-lopinavir-ritonavirtreatment- arms-for-covid-19 Retrieved 31st August 2020

Chen, J.; Xia, L.; Liu, L.; Xu, Q.; Ling, Y.; Huang, D.; Huang, W.; Song, S.; Xu, S.; Shen, Y.; Lu, H. Antiviral activity and safety of darunavir/cobicistat for the treatment of COVID-19. Open Forum Infect. Dis., 2020, 7(7), ofaa241.
[http://dx.doi.org/10.1093/ofid/ofaa241] [PMID: 32671131]

Savarino, A.; Boelaert, J.R.; Cassone, A.; Majori, G.; Cauda, R. Effects of chloroquine on viral infections: An old drug against today’s diseases. Lancet Infect. Dis., 2003, 3(11), 722-727.
[http://dx.doi.org/10.1016/S1473-3099(03)00806-5] [PMID: 14592603]

Vincent, M.J.; Bergeron, E.; Benjannet, S.; Erickson, B.R.; Rollin, P.E.; Ksiazek, T.G.; Seidah, N.G.; Nichol, S.T. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol. J., 2005, 2(1), 69.
[http://dx.doi.org/10.1186/1743-422X-2-69] [PMID: 16115318]

ClinicalTrials.gov. Safety, tolerability and immunogenicinity of a coronavirus-like particle COVID-19 vaccine in adults aged 18-55 years. 2020. Available from: https://clinicaltrials.gov/ct2/show/ NCT04450004

ClinicalTrials.gov. Efficacy and safety of hydroxychloroquine and azithromycin for the treatment of ambulatory patients with mild COVID-19. 2020. Available from: https://clinicaltrials.gov/ct2/ show/NCT04348474 Retrieved 28th August, 2020

Hoffmann, M.; Kleine-Weber, H.; Krüger, N.; Müller, M.; Drosten, C.; Pöhlmann, S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv, 2019. 2020.2001.2031.929042
[http://dx.doi.org/10.1101/2020.01.31.929042]

Gunst, J.D.; Staerke, N.B.; Pahus, M.H.; Kristensen, L.H.; Bodilsen, J.; Lohse, N.; Dalgaard, L.S.; Brønnum, D.; Fröbert, O.; Hønge, B.; Johansen, I.S.; Monrad, I.; Erikstrup, C.; Rosendal, R.; Vilstrup, E.; Mariager, T.; Bove, D.G.; Offersen, R.; Shakar, S.; Cajander, S.; Jørgensen, N.P.; Sritharan, S.S.; Breining, P.; Jespersen, S.; Mortensen, K.L.; Jensen, M.L.; Kolte, L.; Frattari, G.S.; Larsen, C.S.; Storgaard, M.; Nielsen, L.P.; Tolstrup, M.; Sædder, E.A.; Østergaard, L.J.; Ngo, H.T.T.; Jensen, M.H.; Højen, J.F.; Kjolby, M.; Søgaard, O.S. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine, 2021, 35, 100849.
[http://dx.doi.org/10.1016/j.eclinm.2021.100849] [PMID: 33903855]

Hoffmann, M.; Schroeder, S.; Kleine-Weber, H.; Müller, M.A.; Drosten, C.; Pöhlmann, S. Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19. Antimicrob. Agents Chemother., 2020, 64(6), e00754-20.
[http://dx.doi.org/10.1128/AAC.00754-20] [PMID: 32312781]

Quinn, T.M.; Gaughan, E.E.; Bruce, A.; Antonelli, J.; O’Connor, R.; Li, F.; McNamara, S.; Koch, O.; MacIntosh, C.; Dockrell, D.; Walsh, T.; Blyth, K.G.; Church, C.; Schwarze, J.; Boz, C.; Valanciute, A.; Burgess, M.; Emanuel, P.; Mills, B.; Rinaldi, G.; Hardisty, G.; Mills, R.; Findlay, E.; Jabbal, S.; Duncan, A.; Plant, S.; Marshall, A.D.L.; Young, I.; Russell, K.; Scholefield, E.; Nimmo, A.F.; Nazarov, I.B.; Churchill, G.C.; McCullagh, J.S.O.; Ebrahimi, K.H.; Ferrett, C.; Templeton, K.; Rannard, S.; Owen, A.; Moore, A.; Finlayson, K.; Shankar-Hari, M.; Norrie, J.; Parker, R.A.; Akram, A.R.; Anthony, D.C.; Dear, J.W.; Hirani, N.; Dhaliwal, K. Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, pharmacokinetics and pharmacodynamics. medRxiv, 2021, 2021.2010.2006.21264648.

Seifirad, S. Pirfenidone: A novel hypothetical treatment for COVID-19. Med. Hypotheses, 2020, 144, 110005-110005.
[http://dx.doi.org/10.1016/j.mehy.2020.110005] [PMID: 32575019]

ClinicalTrials.gov. A study to evaluate the efficacy and safety of pirfenidone with novel coronavirus infection. , 2020. Available from: https://clinicaltrials.gov/ct2/show/study/NCT04282902

Zhang, F.; Wei, Y.; He, L.; Zhang, H.; Hu, Q.; Yue, H.; He, J.; Dai, H. A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019. Chin. Med. J. (Engl.), 2022, 135(3), 368-370.
[http://dx.doi.org/10.1097/CM9.0000000000001614] [PMID: 34855641]

Ely, E.W.; Ramanan, A.V.; Kartman, C.E.; de Bono, S.; Liao, R.; Piruzeli, M.L.B.; Goldman, J.D.; Saraiva, J.F.K.; Chakladar, S.; Marconi, V.C.; Alatorre-Alexander, J.; Altclas, J.D.; Casas, M. CevoliRecio, V.; Ellerin, T.; Giovanni Luz, K.; Goldman, J.D.; Juliani Souza Lima, M.P.; Khan, A.; Paulin, P.; Procopio Carvalho, A.C.; Rojas Velasco, G.; Saraiva, J.F.K.; Shawa, I.; Simon Campos, J.; Tiffany, B.; Westheimer Cavalcante, A. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: An exploratory, randomised, placebo-controlled trial. Lancet Respir. Med., 2022, 10(4), 327-336.
[http://dx.doi.org/10.1016/S2213-2600(22)00006-6] [PMID: 35123660]

Kuba, K.; Imai, Y.; Rao, S.; Gao, H.; Guo, F.; Guan, B.; Huan, Y.; Yang, P.; Zhang, Y.; Deng, W.; Bao, L.; Zhang, B.; Liu, G.; Wang, Z.; Chappell, M.; Liu, Y.; Zheng, D.; Leibbrandt, A.; Wada, T.; Slutsky, A.S.; Liu, D.; Qin, C.; Jiang, C.; Penninger, J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat. Med., 2005, 11(8), 875-879.
[http://dx.doi.org/10.1038/nm1267] [PMID: 16007097]

ClinicalTrials.gov. Effects of discontinuing renin-angiotensin system inhibitors in patients with COVID-19., 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04351581 Retrieved 31st August, 2020

Vankadari, N. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int. J. Antimicrob. Agents, 2020, 56(2), 105998.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105998] [PMID: 32360231]

Nojomi, M.; Yassin, Z.; Keyvani, H.; Makiani, M.J.; Roham, M.; Laali, A.; Dehghan, N.; Navaei, M.; Ranjbar, M. Effect of Arbidol (Umifenovir) on COVID-19: A randomized controlled trial. BMC Infect. Dis., 2020, 20(1), 954.
[http://dx.doi.org/10.1186/s12879-020-05698-w] [PMID: 33317461]

Yang, C.; Ke, C.; Yue, D.; Li, W.; Hu, Z.; Liu, W.; Hu, S.; Wang, S.; Liu, J. Effectiveness of arbidol for COVID-19 prevention in health professionals. Front. Public Health, 2020, 8, 249.
[http://dx.doi.org/10.3389/fpubh.2020.00249] [PMID: 32574310]

Alavi Darazam, I.; Shokouhi, S.; Mardani, M.; Pourhoseingholi, M.A.; Rabiei, M.M.; Hatami, F.; Shabani, M.; Moradi, O.; Gharehbagh, F.J.; Irvani, S.S.N.; Amirdosara, M.; Hajiesmaeili, M.; Rezaei, O.; Khoshkar, A.; Lotfollahi, L.; Gachkar, L.; Dehbsneh, H.S.; Khalili, N.; Soleymaninia, A.; Kusha, A.H.; Shoushtari, M.T.; Torabinavid, P. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int. Immunopharmacol., 2021, 99, 107969.
[http://dx.doi.org/10.1016/j.intimp.2021.107969] [PMID: 34273635]

Ali, K.; Azher, T.; Baqi, M.; Binnie, A.; Borgia, S.; Carrier, F.M.; Cavayas, Y.A.; Chagnon, N.; Cheng, M.P.; Conly, J.; Costiniuk, C.; Daley, P.; Daneman, N.; Douglas, J.; Downey, C.; Duan, E.; Duceppe, E.; Durand, M.; English, S.; Farjou, G.; Fera, E.; Fontela, P.; Fowler, R.; Fralick, M.; Geagea, A.; Grant, J.; Harrison, L.B.; Havey, T.; Hoang, H.; Kelly, L.E.; Keynan, Y.; Khwaja, K.; Klein, G.; Klein, M.; Kolan, C.; Kronfli, N.; Lamontagne, F.; Lau, R.; Fralick, M.; Lee, T.C.; Lee, N.; Lim, R.; Longo, S.; Lostun, A.; MacIntyre, E.; Malhamé, I.; Mangof, K.; McGuinty, M.; Mergler, S.; Munan, M.P.; Murthy, S.; O’Neil, C.; Ovakim, D.; Papenburg, J.; Parhar, K.; Parvathy, S.N.; Patel, C.; Perez-Patrigeon, S.; Pinto, R.; Rajakumaran, S.; Rishu, A.; Roba-Oshin, M.; Rushton, M.; Saleem, M.; Salvadori, M.; Scherr, K.; Schwartz, K.; Semret, M.; Silverman, M.; Singh, A.; Sligl, W.; Smith, S.; Somayaji, R.; Tan, D.H.S.; Tobin, S.; Todd, M.; Tran, T.V.; Tremblay, A.; Tsang, J.; Turgeon, A.; Vakil, E.; Weatherald, J.; Yansouni, C.; Zarychanski, R. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: A randomized controlled trial. CMAJ, 2022, 194(7), E242-E251.
[http://dx.doi.org/10.1503/cmaj.211698] [PMID: 35045989]

Gottlieb, R.L.; Vaca, C.E.; Paredes, R.; Mera, J.; Webb, B.J.; Perez, G.; Oguchi, G.; Ryan, P.; Nielsen, B.U.; Brown, M.; Hidalgo, A.; Sachdeva, Y.; Mittal, S.; Osiyemi, O.; Skarbinski, J.; Juneja, K.; Hyland, R.H.; Osinusi, A.; Chen, S.; Camus, G.; Abdelghany, M.; Davies, S.; Behenna-Renton, N.; Duff, F.; Marty, F.M.; Katz, M.J.; Ginde, A.A.; Brown, S.M.; Schiffer, J.T.; Hill, J.A. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N. Engl. J. Med., 2022, 386(4), 305-315.
[http://dx.doi.org/10.1056/NEJMoa2116846] [PMID: 34937145]

Hassanipour, S.; Arab-Zozani, M.; Amani, B.; Heidarzad, F.; Fathalipour, M.; Martinez-de-Hoyo, R. The efficacy and safety of Favipiravir in treatment of COVID-19: A systematic review and meta-analysis of clinical trials. Sci. Rep., 2021, 11(1), 11022.
[http://dx.doi.org/10.1038/s41598-021-90551-6] [PMID: 34040117]

Parienti, J.J.; Prazuck, T.; Peyro-Saint-Paul, L.; Fournier, A.; Valentin, C.; Brucato, S.; Verdon, R.; Sève, A.; Colin, M.; Lesne, F.; Guinard, J.; Ar Gouilh, M.; Dina, J.; Vabret, A.; Hocqueloux, L. Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial. EClinicalMedicine, 2021, 38, 100993.
[http://dx.doi.org/10.1016/j.eclinm.2021.100993] [PMID: 34222849]

Tardif, J.C.; Bouabdallaoui, N.; L’Allier, P.L.; Gaudet, D.; Shah, B.; Pillinger, M.H.; Lopez-Sendon, J.; da Luz, P.; Verret, L.; Audet, S.; Dupuis, J.; Denault, A.; Pelletier, M.; Tessier, P.A.; Samson, S.; Fortin, D.; Tardif, J.D.; Busseuil, D.; Goulet, E.; Lacoste, C.; Dubois, A.; Joshi, A.Y.; Waters, D.D.; Hsue, P.; Lepor, N.E.; Lesage, F.; Sainturet, N.; Roy-Clavel, E.; Bassevitch, Z.; Orfanos, A.; Stamatescu, G.; Grégoire, J.C.; Busque, L.; Lavallée, C.; Hétu, P.O.; Paquette, J.S.; Deftereos, S.G.; Levesque, S.; Cossette, M.; Nozza, A.; Chabot-Blanchet, M.; Dubé, M.P.; Guertin, M.C.; Boivin, G. Colchicine for community-treated patients with COVID-19 (COLCORONA): A phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir. Med., 2021, 9(8), 924-932.
[http://dx.doi.org/10.1016/S2213-2600(21)00222-8] [PMID: 34051877]

Dorward, J.; Yu, L.M.; Hayward, G.; Saville, B.R.; Gbinigie, O.; Van Hecke, O.; Ogburn, E.; Evans, P.H.; Thomas, N.P.B.; Patel, M.G.; Richards, D.; Berry, N.; Detry, M.A.; Saunders, C.; Fitzgerald, M.; Harris, V.; Shanyinde, M.; de Lusignan, S.; Andersson, M.I.; Butler, C.C.; Hobbs, F.D.R. Colchicine for COVID-19 in the community (PRINCIPLE): A randomised, controlled, adaptive platform trial. Br. J. Gen. Pract., 2022, 72(720), e446-e455.
[http://dx.doi.org/10.3399/BJGP.2022.0083] [PMID: 35440469]

Group, RECOVERY Collaborative. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet Respir. Med., 2021, 9(12), 1419-1426.

Dequin, P.F.; Heming, N.; Meziani, F.; Plantefève, G.; Voiriot, G.; Badié, J.; François, B.; Aubron, C.; Ricard, J.D.; Ehrmann, S.; Jouan, Y.; Guillon, A.; Leclerc, M.; Coffre, C.; Bourgoin, H.; Lengellé, C.; Caille-Fénérol, C.; Tavernier, E.; Zohar, S.; Giraudeau, B.; Annane, D.; Le Gouge, A. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19. JAMA, 2020, 324(13), 1298-1306.
[http://dx.doi.org/10.1001/jama.2020.16761] [PMID: 32876689]

Crothers, K.; DeFaccio, R.; Tate, J.; Alba, P.R.; Goetz, M.B.; Jones, B.; King, J.T., Jr; Marconi, V.; Ohl, M.E.; Rentsch, C.T.; Rodriguez-Barradas, M.C.; Shahrir, S.; Justice, A.C.; Akgün, K.M. Dexamethasone in hospitalised coronavirus-19 patients not on intensive respiratory support. Eur. Respir. J., 2021.
[PMID: 34824060]

Horby, P.; Lim, W.S.; Emberson, J.R.; Mafham, M.; Bell, J.L.; Linsell, L.; Staplin, N.; Brightling, C.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Green, C.; Felton, T.; Chadwick, D.; Rege, K.; Fegan, C.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Montgomery, A.; Rowan, K.; Juszczak, E.; Baillie, J.K.; Haynes, R.; Landray, M.J. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med., 2021, 384(8), 693-704.
[http://dx.doi.org/10.1056/NEJMoa2021436] [PMID: 32678530]

Maskin, L.P.; Bonelli, I.; Olarte, G.L.; Palizas, F., Jr; Velo, A.E.; Lurbet, M.F.; Lovazzano, P.; Kotsias, S.; Attie, S.; Lopez Saubidet, I.; Baredes, N.D.; Setten, M.; Rodriguez, P.O. High- versus low-dose dexamethasone for the treatment of COVID-19-related acute respiratory distress syndrome: A multicenter, randomized open-label clinical trial. J. Intensive Care Med., 2022, 37(4), 491-499.
[http://dx.doi.org/10.1177/08850666211066799] [PMID: 34898320]

Hammond, Jennifer; Leister-Tebbe, Heidi; Gardner, Annie; Abreu, Paula; Bao, Weihang Wisemandle, Wayne Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. 2022, 386(15), 1397-1408..

Jayk Bernal, A.; Gomes da Silva, M.M.; Musungaie, D.B.; Kovalchuk, E.; Gonzalez, A.; Delos Reyes, V.; Martín-Quirós, A.; Caraco, Y.; Williams-Diaz, A.; Brown, M.L.; Du, J.; Pedley, A.; Assaid, C.; Strizki, J.; Grobler, J.A.; Shamsuddin, H.H.; Tipping, R.; Wan, H.; Paschke, A.; Butterton, J.R.; Johnson, M.G.; De Anda, C. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med., 2022, 386(6), 509-520.
[http://dx.doi.org/10.1056/NEJMoa2116044] [PMID: 34914868]

Group, RECOVERY Collaborative. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 2021, 397(10274), 605-612.

Group, PRINCIPLE Trial Collaborative. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet, 2021, 397(10279), 1063-1074.

Cavalcanti, A.B.; Zampieri, F.G.; Rosa, R.G.; Azevedo, L.C.P.; Veiga, V.C.; Avezum, A.; Damiani, L.P.; Marcadenti, A.; Kawano-Dourado, L.; Lisboa, T.; Junqueira, D.L.M. de Barros e Silva, P.G.M.; Tramujas, L.; Abreu-Silva, E.O.; Laranjeira, L.N.; Soares, A.T.; Echenique, L.S.; Pereira, A.J.; Freitas, F.G.R.; Gebara, O.C.E.; Dantas, V.C.S.; Furtado, R.H.M.; Milan, E.P.; Golin, N.A.; Cardoso, F.F.; Maia, I.S.; Hoffmann Filho, C.R.; Kormann, A.P.M.; Amazonas, R.B.; Bocchi de Oliveira, M.F.; Serpa-Neto, A.; Falavigna, M.; Lopes, R.D.; Machado, F.R.; Berwanger, O.; Berwanger, O. Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19. N. Engl. J. Med., 2020, 383(21), 2041-2052.
[http://dx.doi.org/10.1056/NEJMoa2019014] [PMID: 32706953]

Yang, S.N.Y.; Atkinson, S.C.; Wang, C.; Lee, A.; Bogoyevitch, M.A.; Borg, N.A.; Jans, D.A. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer. Antiviral Res., 2020, 177, 104760.
[http://dx.doi.org/10.1016/j.antiviral.2020.104760] [PMID: 32135219]

Vallejos, J.; Zoni, R.; Bangher, M.; Villamandos, S.; Bobadilla, A.; Plano, F.; Campias, C.; Chaparro Campias, E.; Medina, M.F.; Achinelli, F.; Guglielmone, H.A.; Ojeda, J.; Farizano Salazar, D.; Andino, G.; Kawerin, P.; Dellamea, S.; Aquino, A.C.; Flores, V.; Martemucci, C.N.; Martinez, S.M.; Segovia, J.E.; Reynoso, P.I.; Sosa, N.C.; Robledo, M.E.; Guarrochena, J.M.; Vernengo, M.M.; Ruiz Diaz, N.; Meza, E.; Aguirre, M.G. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect. Dis., 2021, 21(1), 635.
[http://dx.doi.org/10.1186/s12879-021-06348-5] [PMID: 34215210]

Westendorf, Kathryn; Žentelis, Stefanie; Wang, Lingshu; Foster, Denisa; Vaillancourt, Peter; Wiggin, Matthew; Lovett, Erica; van der Lee, Robin; Hendle, Jörg; Pustilnik, Anna; Sauder, J. Michael; Kraft, Lucas; Hwang, Yuri; Siegel, Robert W.; Chen, Jinbiao; Heinz, Beverly A.; Higgs, Richard E.; Kallewaard, Nicole L.; Jepson, Kevin; Goya, Rodrigo; Smith, Maia A.; Collins, David W.; Pellacani, Davide; Xiang, Ping; de Puyraimond, Valentine; Ricicova, Marketa; Devorkin, Lindsay; Pritchard, Caitlin; O’Neill, Aoise; Dalal, Kush; Panwar, Pankaj; Dhupar, Harveer; Garces, Fabian A.; Cohen, Courtney A.; Dye, John M.; Huie, Kathleen E.; Badger, Catherine V.; Kobasa, Darwyn; Audet, Jonathan; Freitas, Joshua J.; Hassanali, Saleema; Hughes, Ina; Munoz, Luis; Palma, Holly C.; Ramamurthy, Bharathi; Cross, Robert W.; Geisbert, Thomas W.; Menacherry, Vineet; Lokugamage, Kumari; Borisevich, Viktoriya; Lanz, Iliana; Anderson, Lisa; Sipahimalani, Payal; Corbett, Kizzmekia S.; Yang, Eun Sung; Zhang, Yi; Shi, Wei; Zhou, Tongqing; Choe, Misook; Misasi, John; Kwong, Peter D.; Sullivan, Nancy J.; Graham, Barney S.; Fernandez, Tara L.; Hansen, Carl L.; Falconer, Ester; Mascola, John R.; Jones, Bryan E.; Barnhart, Bryan C. LYCoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep., 2022, 39(7), 110812.
[http://dx.doi.org/10.1016/j.celrep.2022.110812]

Wang, X.; Guo, X.; Xin, Q.; Pan, Y.; Hu, Y.; Li, J.; Chu, Y.; Feng, Y.; Wang, Q. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin. Infect. Dis., 2020, 71(10), 2688-2694.
[http://dx.doi.org/10.1093/cid/ciaa721] [PMID: 32497196]

Shen, C.; Wang, Z.; Zhao, F.; Yang, Y.; Li, J.; Yuan, J.; Wang, F.; Li, D.; Yang, M.; Xing, L.; Wei, J.; Xiao, H.; Yang, Y.; Qu, J.; Qing, L.; Chen, L.; Xu, Z.; Peng, L.; Li, Y.; Zheng, H.; Chen, F.; Huang, K.; Jiang, Y.; Liu, D.; Zhang, Z.; Liu, Y.; Liu, L. Treatment of 5 critically ill patients with covid-19 with convalescent plasma. JAMA, 2020, 323(16), 1582-1589.
[http://dx.doi.org/10.1001/jama.2020.4783] [PMID: 32219428]

Lead, India to. World’s largest’ convalescent plasma covid-19 clinical trial. 2020. Available from: https://www.biospectrumasia.com/news/49/16116/india-to-lead-worlds-largest-convalescent-plasma-covid-19-clinical-trial.html

Dougan, M.; Nirula, A.; Azizad, M.; Mocherla, B.; Gottlieb, R.L.; Chen, P.; Hebert, C.; Perry, R.; Boscia, J.; Heller, B.; Morris, J.; Crystal, C.; Igbinadolor, A.; Huhn, G.; Cardona, J.; Shawa, I.; Kumar, P.; Adams, A.C.; Van Naarden, J.; Custer, K.L.; Durante, M.; Oakley, G.; Schade, A.E.; Holzer, T.R.; Ebert, P.J.; Higgs, R.E.; Kallewaard, N.L.; Sabo, J.; Patel, D.R.; Dabora, M.C.; Klekotka, P.; Shen, L.; Skovronsky, D.M. Bamlanivimab plus etesevimab in mild or moderate Covid-19. N. Engl. J. Med., 2021, 385(15), 1382-1392.
[http://dx.doi.org/10.1056/NEJMoa2102685]

Dougan, M.; Azizad, M.; Chen, P.; Feldman, B.; Frieman, M.; Igbinadolor, A.; Kumar, P.; Morris, J.; Potts, J.; Baracco, L.; Macpherson, L.; Kallewaard, N.L.; Patel, D.R.; Hufford, M.M.; Wietecha, L.; Chigutsa, E.; Demmon, S.L.; Jones, B.E.; Nirula, A.; Skovronsky, D.M.; Williams, M.; Gottlieb, R.L. Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19. medRxiv, 2022.
[http://dx.doi.org/10.1101/2022.03.10.22272100]

McEneny-King, A.C.; Monteleone, J.P.R.; Kazani, S.D.; Ortiz, S.R. Pharmacokinetic and pharmacodynamic evaluation of ravulizumab in adults with severe coronavirus disease 2019. Infect. Dis. Ther., 2021, 10(2), 1045-1054.
[http://dx.doi.org/10.1007/s40121-021-00425-7] [PMID: 33826106]

Elneil, S.; Lalezari, J.P.; Pourhassan, N.Z. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab. J. Transl. Autoimmun., 2021, 4, 100097.
[http://dx.doi.org/10.1016/j.jtauto.2021.100097] [PMID: 33778462]

Gritti, G.; Raimondi, F.; Ripamonti, D.; Riva, I.; Landi, F.; Alborghetti, L.; Frigeni, M.; Damiani, M.; Micò, C.; Fagiuoli, S.; Cosentini, R.; Lorini, F.L.; Fabretti, F.; Morgan, J.; Owens, B.M.J.; Kanhai, K.; Cowburn, J.; Rizzi, M.; Di Marco, F. Rambaldi, Alessandro Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support. medRxiv, 2020.

Temesgen, Z.; Assi, M.; Vergidis, P.; Rizza, S.A.; Bauer, P.R.; Pickering, B.W.; Razonable, R.R.; Libertin, C.R.; Burger, C.D.; Orenstein, R.; Vargas, H.E.; Varatharaj Palraj, B.R.; Dababneh, A.S.; Chappell, G.; Chappell, D.; Ahmed, O.; Sakemura, R.; Durrant, C.; Kenderian, S.S.; Badley, A. First clinical use of lenzilumab to neutralize GM-CSF in patients with severe COVID-19 pneumonia. medRxiv, 2020.
[http://dx.doi.org/10.1101/2020.06.08.20125369]

Generali, D.; Bosio, G.; Malberti, F.; Cuzzoli, A.; Testa, S.; Romanini, L.; Fioravanti, A.; Morandini, A.; Pianta, L.; Giannotti, G.; Viola, E.M.; Giorgi-Pierfranceschi, M.; Foramitti, M.; Tira, R.A.; Zangrandi, I.; Chiodelli, G.; Machiavelli, A.; Cappelletti, M.R.; Giossi, A.; De Giuli, V.; Costanzi, C.; Campana, C.; Bernocchi, O.; Sirico, M.; Zoncada, A.; Molteni, A.; Venturini, S.; Giudici, F.; Scaltriti, M.; Pan, A. Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study. Int. J. Infect. Dis., 2021, 104, 433-440.
[http://dx.doi.org/10.1016/j.ijid.2020.12.073] [PMID: 33385581]

Pang, J.; Xu, F.; Aondio, G.; Li, Y.; Fumagalli, A.; Lu, M.; Valmadre, G.; Wei, J.; Bian, Y.; Canesi, M.; Damiani, G.; Zhang, Y.; Yu, D.; Chen, J.; Ji, X.; Sui, W.; Wang, B.; Wu, S.; Kovacs, A.; Revera, M.; Wang, H.; Jing, X.; Zhang, Y.; Chen, Y.; Cao, Y. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat. Commun., 2021, 12(1), 814.
[http://dx.doi.org/10.1038/s41467-021-21085-8] [PMID: 33547300]

Perrone, F.; Piccirillo, M.C.; Ascierto, P.A.; Salvarani, C.; Parrella, R.; Marata, A.M.; Popoli, P.; Ferraris, L.; Marrocco-Trischitta, M.M.; Ripamonti, D.; Binda, F.; Bonfanti, P.; Squillace, N.; Castelli, F.; Muiesan, M.L.; Lichtner, M.; Calzetti, C.; Salerno, N.D.; Atripaldi, L.; Cascella, M.; Costantini, M.; Dolci, G.; Facciolongo, N.C.; Fraganza, F.; Massari, M.; Montesarchio, V.; Mussini, C.; Negri, E.A.; Botti, G.; Cardone, C.; Gargiulo, P.; Gravina, A.; Schettino, C.; Arenare, L.; Chiodini, P.; Gallo, C.; Perrone, F.; Piccirillo, M.C.; Schettino, C.; Gravina, A.; Gargiulo, P.; Cardone, C.; Arenare, L.; Ascierto, P.A.; Vitale, M.G.; Trojaniello, C.; Palla, M.; Bianchi, A.A.M.; Botti, G.; De Feo, G.; Miscio, L.; Gallo, C.; Chiodini, P.; Ferraris, L.; Marrocco-Trischitta, M.M.; Froldi, M.; Menicanti, L.; Cuppone, M.T.; Gobbo, G.; Baldessari, C.; Valenti, V.; Castelvecchio, S.; Poli, F.; Giacomazzi, F.; Piccinni, R.; Annnunziata, M.L.; Biondi, A.; Bussolari, C.; Mazzoleni, M.; Giachi, A.; Filtz, A.; Manini, A.; Poletti, E.; Masserini, F.; Conforti, F.; Gaudiano, G.; Favero, V.; Moroni, A.; Viva, T.; Fancoli, F.; Ferrari, D.; Niro, D.; Resta, M.; Ballotta, A.; Poli, M.D.; Ranucci, M.; Ripamonti, D.; Binda, F.; Tebaldi, A.; Gritti, G.; Pasulo, L.; Gaglio, L.; Del Fabbro, R.; Alborghetti, L.; Bonfanti, P.; Squillace, N.; Giustinetti, G.; Columpsi, P.; Cazzaniga, M.; Capici, S.; Sala, L.; Di Sciacca, R.; Mosca, G.; Pirozzi, M.R.; Castelli, F.; Muiesan, M.L.; Franceschini, F.; Roccaro, A.; Salvetti, M.; Paini, A.; Corda, L.; Ricci, C.; Tomasoni, L.; Nasta, P.; Lorenzotti, S.; Odolini, S.; Focà, E.; Roldan, E.Q.; Metra, M.; Magrini, S.; Borghetti, P.; Latronico, N.; Piva, S.; Filippini, M.; Zuccalà, F.; Cattaneo, S.; Scolari, F.; Bossini, N.; Gaggiotti, M.; Properzi, M.; Lichtner, M.; Del Borgo, C.; Marocco, R.; Belvisi, V.; Tieghi, T.; De Masi, M.; Zuccalà, P.; Fabietti, P.; Vetica, A.; Mercurio, V.S.; Carraro, A.; Fondaco, L.; Kertusha, B.; Curtolo, A.; Del Giudice, E.; Lubrano, R.; Zotti, M.G.; Puorto, A.; Ciuffreda, M.; Sarni, A.; Monteforte, G.; Romeo, D.; Viola, E.; Damiani, C.; Barone, A.; Mantovani, B.; Di Sanzo, D.; Gentili, V.; Carletti, M.; Aiuti, M.; Gallo, A.; Meliante, P.G.; Martellucci, S.; Riggio, O.; Cardinale, V.; Ridola, L.; Bragazzi, M.C.; Gioia, S.; Valenzi, E.; Graziosi, C.; Bina, N.; Fasolo, M.; Ricci, S.; Gioacchini, M.T.; Lucci, A.; Corso, L.; Tornese, D.; Nijhawan, P.; Equitani, F.; Cosentino, C.; Palladino, M.; Leonetti, F.; Leto, G.; Gnessi, C.; Campagna, G.; Cesareo, R.; Marrocco, F.; Straface, G.; Mecozzi, A.; Cerbo, L.; Isgrò, V.; Parrocchia, S.; Visconti, G.; Casati, G.; Calzetti, C.; Ariani, A.; Donghi, L.; Salerno, N.D.; Tacconelli, E.; Bertoldi, M.; Cattaneo, P.; Lambertenghi, L.; Motta, L.; Omega, L.; Albano, G.; Parrella, R.; Fraganza, F.; Atripaldi, L.; Montesarchio, V.; Scarano, F.; De Rosa, A.; Buglione, A.; Lavoretano, S.; Gaglione, G.; De Marco, M.; Sangiovanni, V.; Fusco, F.M.; Viglietti, R.; Manzillo, E.; Rescigno, C.; Pisapia, R.; Plamieri, G.; Maraolo, A.; Calabria, G.; Catalano, M.; Fiorentino, G.; Annunziata, A.; Polistina, G.; Imitazione, P.; Mollica, M.; Esposito, V.; D’Abraccio, M.; Punzi, R.; Bianco, V.; Sbreglia, C.; Del Vecchio, R.F.; Bordonali, A.; Franco, A.; Salvarani, C.; Massari, M.; Dolci, G.; Salsi, P.; Virzì, G.; Ornella, C.; Molteni, A.; Gennarini, S.; Gnudi, U.; Ricci, M.A.; Titolo, G.; Mensi, G.; Vuotto, P.; Gasperini, B.; Mancini, M.; Pasquini, Z.; Spanu, P.; Clementi, S.; Pierini, S.; Bokor, D.; Gori, D.; Ciofetti, M.; Caimi, M.; Bettazzi, L.; Allevi, E.; Furiani, S.; Capitanio, C.; Mastropasqua, B.; Fara, C.; Pulitanò, G.; Matsuno, J.S.; Porta, F.D.; Dolfini, V.; Beyene, N.B.; Bezzi, M.; Novali, M.; Viale, P.; Tedeschi, S.; Pascale, R.; Bruno, R.; Di Filippo, A.; Sachs, M.; Oggionni, T.; Di Stefano, M.; Mengoli, C.; Facchini, C.; Daniele, D.N.; Frausini, G.; Mucci, L.; Tedesco, S.; Girolimetti, R.; Manfredini, E.; Di Carlo, A.M.; Espinosa, E.; Dennetta, D.; Ticinesi, A.; Meschi, T.; Nouvenne, A.; Claudio, N.; Vitale, F.; Saracco, M.; Codeluppi, M.; Fronti, E.; Ferrante, P.; Nespola, G.A.; Francisci, D.; Tosti, A.; Carbonelli, C.M.; Greco, A.; Tinti, M.G.; Stellini, R.; Appiani, C.; Reghenzi, P.; Poletti, V.; Ravaglia, C.; Tacconi, D.; Malcontenti, C.; Sainaghi, P.P.; Landi, R.; Vassia, V.; Rizzi, E.; Bellan, M.; Rossati, A.; Castello, L.; Mastroianni, C.M.; Russo, G.; Fabio, T.; Serino, F.S.; Brollo, L.; Momesso, E.; Turati, M.L.; Monforte, A.D.; Marchetti, G.; Boni, F.; Teopompi, E.; Trenti, C.; Boracchia, L.; Minelli, E.; Fontana, M.; Ghidoni, G.; Matei, A.; Caruso, A.; Arcoleo, G.; Camarda, G.; Catalano, F.; Spatafora, M.; Bettega, D.; Andreoni, M.; Teti, E.; Sarmati, L.; Di Lorenzo, A.; Celeste, M.; Baratto, F.; Monticelli, J.; Criveller, P.; Andrea, A. Anselmo; Riccio; Castellano, M.; Cappelli, C.; Corvini, F.; Zanini, B.; Crippa, M.; Ronconi, M.; Costa, R.; Casella, S.; Brentana, L.; Bernardi, L.; Frascati, A.; Panese, S.; Presotto, F.; Michieletto, L.; Bernardi, C.; Fusar, M.; Agnoletti, V.; Farina, M.; Russo; Lavorini, F.; Ginanni, R.; Palmieri, F.; Mosti, S.; Amaglio, A.; Cattaneo, A.; Cirri, S.; Montisci, A.; Gallazzi, C.; Cosseta, D.; Baronio, B.; Rampa, L.; Maggi, P.; Messina, V.; Negri, E.A.; Sabatti, M.C.; Palumbo, M.; Mazzone, A.; Faggioli, P.; Bussini, L.; Fornaro, G.; Volpato, F.; Imperiale, D.; Manno, E.; Ferreri, E.; Martelli, D.; Verhovez, A.; Giorgis, S.; Faccio, L.; Quadri, R.D.; Negro, C.; Converso, M.; Bosco, F.; Prandini, P.; Cocchi, S.; Manfrin, V.; Del Punta, V.; Mazzola, G.; Sportato, G.; Romagnoli, M.; Cristini, F.; Facondini, F.; Perin, T.; Boschi, A.; Mussini, C.; Meschiari, M.; Guaraldi, G.; Modica, S.; Moneta, S.; Boccalatte, D.; Ricci, C.; Marchetti, V.; Amadasi, S.; Ebbreo, G.; Dalè, M.; Tura, P.; Rizzoni, D.; Boari, G.E.M.; Bonetti, S.; Marini, E.; Daniele, I.; Grossi, P.A.; Delfrate, N.W.; Bernhart, O.; Spizzo, G.; Mahlknecht, K.; Volkl, T.; Di Pietro, M.A.; Trezzi, M.; Monacci, C.; Peris, A.; Bonizzoli, M.; Cavanna, L.; Moroni, C.; Stroppa, E.M.; Manini, A.; Savio, M.C.; Gatti, F.; Bartolaminelli, C.; Petrosillo, N.; Donno, D.R.; Taglietti, F.; Topino, S.; Chinello, P.; Galati, V.; D’offizi, G.; Taibi, C.; Cimolato, B.; Moroni, F.; Palagano, N.; Pelagatti, L.; Cristiana, S.; Landini, G.; Amitrano, M.; Raimondo, M.; Mangiacapra, S.; Romano, A.; Atteno, M.; Casinelli, K.; Uccella, I.; Harari, S.; Caminati, A.; Lipani, F.; Di Perri, G.; Calcagno, A.; Calleri, G.; Montrucchio, C.; Caputo, A.M.; Cozzio, S.; Donne, L.D.; Bassetti, M.; Malgorzata, M.; Nicolini, L.A.; Russo, C.; Sepulcri, C.; Beltramini, S.; Mina, F.; Puoti, M.; Gandino, A.; Langer, T.; D’amico, F.; Berlendis, M.; Rocchetti, C.; Cettolo, F.; Gabriele, F.; Bocchi, P.; Cioni, G.; Cappi, C.; Corcione, S.; De Rosa, F.G.; Scabini, S.; Canta, F.; Pinna, S.M.; Pensa, A.; Blanc, P.; Suardi, L.R.; Pallotto, C.; Rocco, M.; Cirasa, M.T.; Spinicci, M.; Mencarini, J.; Zammarchi, L.; Giovanni, C.; Sciolè, K.; Bassi, F.; Bianchi, M.; Frigerio, S.; Spaziani, S.; Nucera, A.; Rizzardini, G.; Cossu, M.V.; Antivalle, M.; Carpinteri, G.; Macheda, S.; Labate, D.; Bottiroli, M.; Romano, A.; Erne, E.M.; Cristina, Z.; Di Biase, V.; Malberti, F.; Montani, G.; Poisa, P.; Bettini, D.; Cauda, R.; Ciccullo, A.; Riccardi, N.; Angheben, A.; Turrini, M.; Clerici, R.; Gardellini, A.; Liparulo, L.; Rossini, T.; Ucciferri, C.; Cipollone, F.; Vecchiet, J.; Nico, A.; Marra, L.; Leone, A.; Sdanganelli, A.; Palmiotti, G.A.; D’Alagni, G.; Santantonio, T.A.; Lo Caputo, S.; Bottalico, I.; Ponticiello, A.; Di Perna, F.; Bernardi, E.; Beltrame, A.; Bravi, S.; David, M.; Bernardi, P.; Galante, D.; Uccelli, M.C.; Prestini, K.; Drera, M.; Zini, E.; Peregrinelli, A.; Blanzuoli, L.; Benedetti, V.; Calvi, R.; Scaglione, N.; Nallino, G.; Bonazzi, M.; Crespi, T.; Masolin, T.; Regazzetti, A.; Cerri, M.C.; Maffezzini, E.; Piazza, M.; Papetti, C.; De Filippi, C.; Roveda, E.; Cipolla, G.; Scozzafava, M.; Crepaldi, M.; Henchi, S.; Vanoni, N.; Repossi, A.; Vezzoli, M.; Scorletti, E.; Perugini, O.; Pasini, S.M.; Pacetti, V.; Ferrari, L.; de Paduanis, G.A.; del Duca, S.; dell’Ara, F.; Brocchieri, A.; Minoja, G.; Storti, E.; Pitagora, L.; Costa, I.; Delfanti, F.; Orlandi, M.; Ruggeri, R.; Ruggieri, L.; Livigni, S.; Silengo, D.; Ageno, W.; Pedrini, L.; Artiol, S.; Morbidoni, L.; De Donno, G.; Ravagnani, V.; Inglese, F.; Scotton, P.G.; Costantini, P.; Delucchi, M.; Clini, E.; Ansuini, A.; Marco, B.; Giuseppe, L.; Vincenzo, B.; Rastelli, G.; Doria, A.; Vianello, A.; Cattelan, A.M.; Bindoli, S.; Felicietti, M.; Canetta, C.; Scartabellati, A.; Accordino, S.; Ferrara, M.; Cocco, L.; Cirillo, F.; Pace, E.; De Caro, M.; Alberico, M.; Benigni, G.; Damiano, T.; Fusco, P.; Iuorio, A.; Torretta, G.; Racagni, M.; Muttini, S.; Sala, G.; Ghiringhelli, P.; Chiumiento, F.; Baccari, L.; Luca, B.; Bocchi, F.; Benatti, F.; Catellani, J.; Coppola, M.; Papi, A.; Bosco, E.; Bonizzoli, M.; Lazzeri, C.; Cesira, N.; Puttini, C.; Carli, T.; Croci, L.; Corridi, M.; Arlotti, M.; Guerrini, G.; Cola, L.; Romanelli, M.; Bonifazi, M.; Gasparini, S.; Mei, F.; Cerutti, E.; Lacedonia, D.; Santoro, A.; Guidelli, G.M.; Greco, S.; Castellan, A.; Infantino, G.; Camici, L.; Frigieri, F.C.; Pavoni, V.; Migliori, L.; Rossetti, B.; Montagnini, F.; Mauro, I.; Genovese, E.; Capuozzo, A.; Vitiello, L.; Sirignano, E.; Gnesin, P.; Servillo, G.; Marinelli, A.; Pasero, D.; Babudieri, S.; Madeddu, G.; De Vito, A.; Casadio, L.; Ranghitta, M.; Passalacqua, R.; Antonio, F.; Gentile, I.; Buonomo, A.R.; Scotto, R.; Zappulo, E.; Dell’Aquila, G.; Bianchetti, A.; Guerini, F.; Vallone, A.; Oppedisano, P.; Pusterla, L.; Giglio, O.; Russo, G.; Sartori, E.; Zanardini, C.; Gatti, P.; Vincenzo, V.; Piconi, S.; Molteni, C.; Dognini, G.; Cosimo, F.; Guarneri, L.; Pulvirenti, F.; Mondino, V.; Traballi, G.; Iemoli, E.; Grisolia, A.; Giorgi, R.; Nucera, G.; Raffaelli, V.; Marino, P.; Negro, E.; Serati, L.; Silvia, T.; Iacobello, C.; Strano, G.; Boglione, L.; Catania, A.; Gipponi, P.; Di Cato, L.; Panaccione, A.; Vitale, G.; Crippa, I.A.; Giacomini, M.; Basile, A.; Andrea, B.; Tundo, P.; Buzzigoli, S.; Palmiero, G.; Magnaca, A.; Silva, M.; Ricci, M.; Crespi, S.; Pasquino, B.; Consales, G.; Bragantini, D.; Mastroianni, F.; Righetti, G.; Scarafino, A.; Bitetto, M.; Franzetti, F.; Piga, S.; Delmonte, V.; Carbonara, S.; Losappio, R.; Dejaco, C.; Mastroianni, C.; Del Bono, V.; Gilioli, F.; Barzan, D.; De Struppi, S.; Carlotto, A.; Guadagnin, M.L.; Girardis, M.; Bertellini, E.; Dentali, F.; Foresta, G.; Baratta, A.; Viviani, R.; Agrati, A.M.; Perego, G.B.; Montineri, A.; Manuele, R.; Bonfante, S.; Aquilini, D.; Prozzo, A.; Santopuoli, D.; Di Rosa, Z.; Alborghetti, A.; Peci, P.; Bakhtadze, N.; Pandini, C.S.; Casati, G.; Ashofarir, N.; Casella, G.; Spagnolli, W.; Urru, S.; Marchesoni, I.; Caminiti, G.; Argilloni, E.; Danieli, E.; Ghirardi, G.; Antonioli, C.M.; Lipari, A.; Zavarise, P.; Kokaly, F.; Polati, E.; Gottin, L.; Lucernoni, P.; De Conti, F.; Marcon, E.; Pontali, E.; Vacca, E.B.; Saffioti, C.; Zunino, A.; Pognuz, E.R.; Berlot, G.; Saltori, M.; Tedesco, A.; Agostini, C.; Di Rosolini, M.A.; Marino, F.; Bellinzona, G.; Grassi, W.; Di Carlo, M.; Scimonello, G.; Nonini, S.; Mondino, M.; Mantovani, L.F.; Tenti, E.; Tropea, C.M.G.; Di Stefano, D.E.; Guelfi, P.; Dagna, L.; Morgana, G.; Montemurro, L.; Girelli, D.; Crisafulli, E.; Maroccia, A.; Cemuschi, A.M.; Bernasconi, M.; Zummo, U.; Barbato, V.; Bevilacqua, S.; Buonfanti, G.; Canzanella, G.; De Matteis, G.; Florio, M.; Martino, M.; Ribecco, M.T.; Romano, F.; Savio, A.; Sparavigna, L.; Curvietto, M.; Citarella, M.; Nava, V.; Maggioni, P.; Magni, M.; Iommelli, C.; Bianco, A.; Corsini, R.; Valli, L.; Ruggieri, M.P.; Melica, T.; Ferrari, A.; Cicognini, D.; Delliponti, M.; Zuccarini, A.; Ciani, S.; Raffaeli, D.; Donati, L.; Cannizzo, S.; Lui, S.; Santini, L.; Roncaglia, E.; Mighali, P.; Eisendle, F.; Cerino, G.; Citterio, C.; Di Nunzio, C.; Mancini, A.; Lamonica, S.; Resimini, S.; Sarteschi, G.; Pavei, C.; Battistini, N.; Gazzola, O.E.; Miceli, M.; Pontiggia, S.; Lonati, V.; Giannandrea, G.; Sortino, C.; Ravani, S.; Uggeri, C.; Jocollé, G.; Baré, C.; Baroni, I.; De Candia, D.; Fiorini, B.; Chierico, K.; Romeo, F.; Bottega, R.; Boccasile, L.; Corsaro, A.; Spadoni, C.; Chiari, S.; Ercolino, G.; Dell’uomo, V.; Viri, S.; Minato, M.; Gazzola, L.; Dorina, B.; Gianelli, D.; Maspero, S.; Farinazzo, M.; Zanini, P.; Sangiovanni, A.; Del Giudice, A.; Dragonetti, M.M.; Bordignon, S.; Machiavelli, A.M.; Chiodelli, G.; Spatarella, M.; Zenoni, D.; Beretta, F.N.; Santilli, G.; Badagliacca, R.; Angileri, M.; Giannelli, L.; Campomori, A.; Maimone, P.; Fadda, A.; Faoro, S.; Pisterna, A.; Cacopardo, B.; Marino, A.; Pampaloni, A.; Celesia, B.M.; Cinnella, G.; Labella, D.; Caporusso, R.R.; Danzi, M.; Fiscon, M.; Malena, M.; Fendt, D.; Nardi, S.; Stobbione, P.; Savi, M.L.; De Monte, A.; Scala, A.; Liberato, N.L.; Luchi, S.; Vincenti, A.; Cabrini, L.; Pinelli, G.; Brugioni, L.; Potenza, D.; Numis, F.G.; Porta, G.; D’amico, M.; Iengo, B.; Angarano, G.; Saracino, A.; Blasi, L.; De Negri, P.; Angelici, S.; Farina, A.; Martino, G.P.; Bitti, G.; Tedeschi, A.; De Ponti, S.; Agostinone, A.; Parruti, G.; Consorte, A.; Frattari, A.; Filippelli, A.; Pagliano, P.; Masullo, A.; Sellitto, C.; Reta, M.; Rossi, N.; Raumer, L.; Andreassi, S.; Brancaleoni, P.; Carai, A.; Salerno, A.M.; Marinangeli, F.; Mariani, R.; Ciccone, A.; Meschini, C.; Santoboni, G.; Angrisani, C.; Micarelli, D.; Tarquini, G.; Fregoni, V.; Volta, C.A.; Cherubini, A.; Del Prete, M.S.; Ciarrochi, E.; Tasca, F.; Ballarin, A.; Bianchin, A.; Flocco, R.; Cuzzone, V.; Carpinteri, M.; Gallotti, P.; Torre, F.; Zannetti, P.; Crapis, M.; Venturini, S.; Barattini, M.; Gori, G.; Mastroianni, A.; De Stefano, G.; Gilio, M.; Rapisarda, G.; Gulisano, L.; Granata, M.L.; Saglimbene, S.; Montalto, M.T.; Grasso, I.; De Luca, S.; Magro, G.; Messina, F.; Scapino, B.; Abrate, P.; Francisco, C.; Pesce, L.; Navarra, M.; Agosti, M.; Pagani, S.; Piluso, M.; Ricioppo, A.; Tognella, S.; Rovere, P.; Vincenzi, M.; Ghirardi, L.; Generali, D.; Ingrosso, M.; Desiderio, E.; Molaro, R.; Vitiello, S.; Mastroianni, A.; Lancione, L.; Paone, T.C.; Meli, A.; Mainardi, S.; Rastellino, V.; Ursillo, A.; di Grigoli, P.; Bovetto, E.; Stefanetto, I.M.; Mazzola, F.; Daniele, A.; Bisio, C.; Delnero, P.; Morando, G.; Nava, A.; Francesco, L.; Fiammengo, F.; Regis, M.; Roccatello, D.; Sabato, E.; Liccardi, M.M.; Bretto, C.; Lutri, L.; Castenetto, E.; Roberti, G.; Guidi, M.F.; Bini, F.; Zappa, M.C.; Trequattrini, T.; Rivitti, R.; Vigliarolo, R.; Succu, A.; Lilli, M.; Serao, M.; Giogré, G.; Ruggieri, A.; Flores, K.; Vairo, G.; Satira, R.; Lingua, A.; Spina, R.; Nicastri, E.; Maffongelli, G.; Barreca, F.; Scollet, S.; Franchi, F.; Fabbri, C.; Minuz, P.; Dalbeni, A.; Zanatta, P.; Gelormini, D.; Mandelli, A.; Galderisi, F.; Zoia, E.; Marchi, M.R.; De Almeida Neves, N.; Carbone, G.; Di Caterino, E.; Petrone, A.; Usai, C.A.; Bandiera, F.; Monti, R.; Hofer, A.; Castiglione, G.; Angeletti, C.; Tarsia, P.; Veronese, L.; Artoni, P.D.; Larussa, D.; Fumagalli, R.; Brioschi, P.; Cerutti, A.; Pasquino, P.; Gilberto, F.; Cantadori, L.; Tomasoni, G.; Tomasoni, L.R.; Coppola, N.; Spolveri, S.; Pollastri, C.; Fico, L.; Principi, T.; Pierantozzi, S.; Fontana, C.; Lubrano, G.; Martinelli, L.; Bravi, S.; Navalesi, P.; Serra, E.; Cogi, E.; Manzi, A.; Furino, E.; Dasseni, N.; Gentilini, C.; Benatti, E.; Pignatti, A.; Aiello, G.; Milia, M.; Covesnon, M.G.; Brianti, A.; Francesco, C.; Ilaria, B.; Pagnozzi, F.; Mietta, S.; Rossi, A.; Maroni, L.; Borroni, V.; Bellintani, C.; Sgarabotto, C.; Bizzotto, G.; Bucci, L.; Spagnuolo, G.; Agostini, M.; Caria, F.C.; Testa, F.; De Palma, R.; Murdaca, G.; Zanolini, G.; Sala, N.; Righini, E.; Pontremoli, R.; Aondio, G.; Riccardi, F.; De Cristoforo, M.G.; De Michele, F.; Storti, A.; Perra, R.; Deidda, S.; Enrica, C.; Valastro, F.; Pierfranceschi, M.G.; De Gennaro, F.; Nardecchia, A.L.; Castellini, M.; Buetto, G.; Ippoliti, G.; Sicheri, D.; Bottoli, M.G.; De Arroyabe, B.M.L.; Versaci, A.; Di Cura Villa Giada Pallotti, C.; Civita, M.; Grio, M.; Liuzzi, N.; Molino, P.; Pastorelli, M.; Ricchiardi, A.; Varbella, F.; Zeme, A.D.; Sighieri, C.; Portale, G.; Olivetti, A.; Pagnoni, C.; Moschini, G.; Boni, S.; Guerra, A.; Scudellari, R.; Vella, S.; Inchiostro, S.; Piazza, O.; Guarino, S.; Aldegheri, G.; Napoli, G.; Morettini, A.; Caldini, E.; Menicacci, L.; Pieralli, F.; Torrini, M.; Poggesi, L.; Visetti, E.M.; Mangano, C.; Visconti, S.; Maietta, P.; Banfi, E.; Cartella, S.; Venturi, B.; Nuceri, A.; Chiesa, E.; Pacentra, E.; Panzolato, G.; Giannotti, M.; Bianchi, C.; Pietrangelo, A.; Para, O.; Rutili, M.S.; Russo, R.; Lanfranco, M.; Scalabrino, E.; Tafuri, A.; Perfetti, E.; Chiarello, T.; Cancanelli, L.; Otero, M.; Pannella, G.; Bellucci, F.; Ferrero, G.; Vico, C.; Stillante, M.S.; D’Andrea, G.; Amoroso, F.; Arcidiacono, A.; Bella, A.M.; Belsito, A.; Berté, Y.; Carubia, G.; Caruso, M.G.; Casella, O.; Chiereleson, F.; Costa, C.; De Franco, D.; Germanà, G.; Messina, A.; Musumeci, D.; Noto, C.; Valenti, M.; Sorrentino, C.; Panico, R.; Schettino, G.; Piccoli, J.; Pepe, A.; De Rosa, F.; Ottaviano, M.; Marrazzo, G.; Raponi, G.; Diberardino, S.; Bausi, S.; Ferrari, A.; Marini, S.F.; Giubellino, E.; Innocenti, G.; Gugliemi, G.; Maccari, D.; Baciu, I. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J. Transl. Med., 2020, 18(1), 405.
[http://dx.doi.org/10.1186/s12967-020-02573-9] [PMID: 33087150]

Norton, T.; Ali, S.; Sivapalasingam, S.; Gao, H.; Bhore, R.; Hooper, A.T.; Hamilton, J.D.; Musser, B.J.; Rofail, D. Im, Joseph; Perry, Christina; Pan, Cynthia; Hosain, Romana; Mahmood, Adnan; Davis, John D.; Turner, Kenneth C.; Baum, Alina; Kyratsous, Christos A.; Kim, Yunji; Cook, Amanda; Kampman, Wendy; Graber, Ximena; Acloque, Gerard; Sachdeva, Yessica; Bocchini, Joseph A.; Kohli, Anita; Kowal, Bari REGEN-COV antibody combination in outpatients with covid-19 – phase 1/2 results. medRxiv, 2022.
[http://dx.doi.org/10.1101/2021.06.09.21257915]

Boyapati, A.; Wipperman, M.F.; Ehmann, P.J.; Hamon, S.; Lederer, D.J.; Waldron, A.; Flanagan, J.J.; Karayusuf, E.; Bhore, R.; Nivens, M.C.; Hamilton, J.D.; Sumner, G.; Sivapalasingam, S. Baseline severe acute respiratory syndrome viral load is associated with coronavirus disease 2019 severity and clinical outcomes: Post hoc analyses of a phase 2/3 trial. J. Infect. Dis., 2021, 224(11), 1830-1838.
[http://dx.doi.org/10.1093/infdis/jiab445] [PMID: 34496013]

Bian, H.; Zheng, Z.H.; Wei, D.; Wen, A.; Zhang, Z.; Lian, J.Q.; Kang, W.Z.; Hao, C.Q.; Wang, J.; Xie, R.H.; Dong, K.; Xia, J.L.; Miao, J.L.; Kang, W.; Li, G.; Zhang, D.; Zhang, M.; Sun, X.X.; Ding, L.; Zhang, K.; Jia, J.; Ding, J.; Li, Z.; Jia, Y.; Liu, L.N.; Zhang, Z.; Gao, Z.W.; Du, H.; Yao, N.; Wang, Q.; Wang, K.; Geng, J.J.; Wang, B.; Guo, T.; Chen, R.; Zhu, Y.M.; Wang, L.J.; He, Q.; Yao, R.R.; Shi, Y.; Yang, X.M.; Zhou, J.S.; Ma, Y.N.; Wang, Y.T.; Liang, X.; Huo, F.; Wang, Z.; Zhang, Y.; Yang, X.; Zhang, Y.; Gao, L.H.; Wang, L.; Chen, X.C.; Tang, H.; Liu, S.S.; Wang, Q.Y.; Chen, Z.N.; Zhu, P. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: A randomized phase 1 and an exploratory phase 2 trial. Signal Transduct. Target. Ther., 2021, 6(1), 194.
[http://dx.doi.org/10.1038/s41392-021-00603-6] [PMID: 34001849]

Patton, J.S.; Fishburn, C.S.; Weers, J.G. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc., 2004, 1(4), 338-344.
[http://dx.doi.org/10.1513/pats.200409-049TA] [PMID: 16113455]

Labiris, N.R.; Dolovich, M.B. Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol., 2003, 56(6), 588-599.
[http://dx.doi.org/10.1046/j.1365-2125.2003.01892.x] [PMID: 14616418]

Sahakijpijarn, S.; Moon, C.; Koleng, J.J.; Christensen, D.J.; Williams, R.O., III Development of remdesivir as a dry powder for inhalation by thin film freezing. Pharmaceutics, 2020, 12(11), 1002.
[http://dx.doi.org/10.3390/pharmaceutics12111002] [PMID: 33105618]

Ali, Z.A.; El-Mallakh, R.S. Nebulized lidocaine in covid-19, an hypothesis. Med. Hypotheses, 2020, 144, 109947.
[http://dx.doi.org/10.1016/j.mehy.2020.109947]

Ramakrishnan, S.; Nicolau, D.V., Jr; Langford, B.; Mahdi, M.; Jeffers, H.; Mwasuku, C.; Krassowska, K.; Fox, R.; Binnian, I.; Glover, V.; Bright, S.; Butler, C.; Cane, J.L.; Halner, A.; Matthews, P.C.; Donnelly, L.E.; Simpson, J.L.; Baker, J.R.; Fadai, N.T.; Peterson, S.; Bengtsson, T.; Barnes, P.J.; Russell, R.E.K.; Bafadhel, M. Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir. Med., 2021, 9, 763-712.
[http://dx.doi.org/10.1016/S2213-2600(21)00160-0]

He, S.; Gui, J.; Xiong, K.; Chen, M.; Gao, H.; Fu, Y. A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. J. Nanobiotechnology, 2022, 20(1), 101.
[http://dx.doi.org/10.1186/s12951-022-01307-x] [PMID: 35241085]

Yu, J.; Lu, X.; Tong, L.; Shi, X.; Ma, J.; Lv, F.; Wu, J.; Pan, Q.; Yang, J.; Auid-Orcid Cao, H.; Li, L. Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019. Br. J. Clin. Pharmacol., 2021, 87(12), 4737-4746.
[http://dx.doi.org/10.1111/bcp.14898]

Stone, K.C.; Mercer, R.R.; Gehr, P.; Stockstill, B.; Crapo, J.D. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol., 1992, 6(2), 235-243.
[http://dx.doi.org/10.1165/ajrcmb/6.2.235] [PMID: 1540387]

Groneberg, D.A.; Witt, C.; Wagner, U.; Chung, K.F.; Fischer, A. Fundamentals of pulmonary drug delivery. Respir. Med., 2003, 97(4), 382-387.
[http://dx.doi.org/10.1053/rmed.2002.1457] [PMID: 12693798]

Chono, S.; Tanino, T.; Seki, T.; Morimoto, K. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J. Drug Target., 2006, 14(8), 557-566.
[http://dx.doi.org/10.1080/10611860600834375] [PMID: 17043040]

Lauweryns, J.M.; Baert, J.H. Alveolar clearance and the role of the pulmonary lymphatics. Am. Rev. Respir. Dis., 1977, 115(4), 625-683.
[PMID: 322558]

Rejman, J.; Oberle, V.; Zuhorn, I.S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J., 2004, 377(1), 159-169.
[http://dx.doi.org/10.1042/bj20031253] [PMID: 14505488]

Lee, E.S.; Kwon, M.J.; Na, K.; Bae, J.H. Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex. Colloids Surf. B Biointerfaces, 2007, 55(1), 125-130.
[http://dx.doi.org/10.1016/j.colsurfb.2006.11.024] [PMID: 17178450]

Dastidar, D.G.; Das, A.; Datta, S.; Ghosh, S.; Pal, M.; Thakur, N.S.; Banerjee, U.C.; Chakrabarti, G. Paclitaxel-encapsulated core–shell nanoparticle of cetyl alcohol for active targeted delivery through oral route. Nanomedicine (Lond.), 2019, 14(16), 2121-2150.
[http://dx.doi.org/10.2217/nnm-2018-0419] [PMID: 31411540]

Shah, M.; Agrawal, Y.K.; Garala, K.; Ramkishan, A. Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride. Indian J. Pharm. Sci., 2012, 74(5), 434-442.
[http://dx.doi.org/10.4103/0250-474X.108419] [PMID: 23716872]

Magalhães, J.; Pinheiro, M.; Drasler, B.; Septiadi, D.; Petri-Fink, A.; Santos, S.G.; Rothen-Rutishauser, B.; Reis, S. Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model. Nanomedicine (Lond.), 2020, 15(3), 259-271.
[http://dx.doi.org/10.2217/nnm-2019-0256] [PMID: 31789097]

Varshosaz, J.; Ghaffari, S.; Mirshojaei, S.F.; Jafarian, A.; Atyabi, F.; Kobarfard, F.; Azarmi, S. Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. BioMed Res. Int., 2013, 2013, 1-8.
[http://dx.doi.org/10.1155/2013/136859] [PMID: 23984315]

Kesharwani, R.; Sachan, A.; Singh, S.; Patel, D. Formulation and evaluation of Solid Lipid Nanoparticle (SLN) based topical gel of etoricoxib. J. Appl. Pharm. Sci., 2016, 6, 124-131.
[http://dx.doi.org/10.7324/JAPS.2016.601017]

Beniwal, A.; Choudhary, H. Rosuvastatin calcium-loaded Solid Lipid Nanoparticles (SLN) using design of experiment approach for oral delivery. International Journal of Chemical and Life Sciences, 2017, 6(5), 2029.
[http://dx.doi.org/10.21746/ijcls.2017.5.1]

Saari, M.; Vidgren, M.T.; Koskinen, M.O.; Turjanmaa, V.M.H.; Nieminen, M.M. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int. J. Pharm., 1999, 181(1), 1-9.
[http://dx.doi.org/10.1016/S0378-5173(98)00398-6] [PMID: 10370197]

Lin, C.; Wong, B.C.K.; Chen, H.; Bian, Z.; Zhang, G.; Zhang, X.; Kashif Riaz, M.; Tyagi, D.; Lin, G.; Zhang, Y.; Wang, J.; Lu, A.; Yang, Z. Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy. Sci. Rep., 2017, 7(1), 1097.
[http://dx.doi.org/10.1038/s41598-017-00957-4] [PMID: 28428618]

Muppidi, K.; Wang, J.; Betageri, G.; Pumerantz, A.S. PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrob. Agents Chemother., 2011, 55(10), 4537-4542.
[http://dx.doi.org/10.1128/AAC.00713-11] [PMID: 21788465]

Willis, L.; Hayes, D., Jr; Mansour, H.M. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery. Lung, 2012, 190(3), 251-262.
[http://dx.doi.org/10.1007/s00408-011-9360-x] [PMID: 22274758]

Bassetti, M.; Vena, A.; Russo, A.; Peghin, M. Inhaled liposomal antimicrobial delivery in lung infections. Drugs, 2020, 80(13), 1309-1318.
[http://dx.doi.org/10.1007/s40265-020-01359-z] [PMID: 32691293]

Lim, Y.H.; Tiemann, K.M.; Hunstad, D.A.; Elsabahy, M.; Wooley, K.L. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2016, 8(6), 842-871.
[http://dx.doi.org/10.1002/wnan.1401] [PMID: 27016134]

Park, C.W.; Li, X.; Vogt, F.G.; Hayes, D., Jr; Zwischenberger, J.B.; Park, E.S.; Mansour, H.M. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Int. J. Pharm., 2013, 455(1-2), 374-392.
[http://dx.doi.org/10.1016/j.ijpharm.2013.06.047] [PMID: 23820131]

Dawson, M.; Wirtz, D.; Hanes, J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J. Biol. Chem., 2003, 278(50), 50393-50401.
[http://dx.doi.org/10.1074/jbc.M309026200] [PMID: 13679362]

Forier, K.; Messiaen, A.S.; Raemdonck, K.; Deschout, H.; Rejman, J.; De Baets, F.; Nelis, H.; De Smedt, S.C.; Demeester, J.; Coenye, T.; Braeckmans, K. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. Nanomedicine (Lond.), 2013, 8(6), 935-949.
[http://dx.doi.org/10.2217/nnm.12.129] [PMID: 23035662]

Chen, E.Y.T.; Wang, Y.C.; Chen, C.S.; Chin, W.C. Functionalized positive nanoparticles reduce mucin swelling and dispersion. PLoS One, 2010, 5(11), e15434.
[http://dx.doi.org/10.1371/journal.pone.0015434] [PMID: 21085670]

Jokerst, J.V.; Lobovkina, T.; Zare, R.N.; Gambhir, S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.), 2011, 6(4), 715-728.
[http://dx.doi.org/10.2217/nnm.11.19] [PMID: 21718180]

Paul, P.; Sengupta, S.; Mukherjee, B.; Shaw, T.K.; Gaonkar, R.H.; Debnath, M.C. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice. Nanomedicine (Lond.), 2018, 13(5), 501-520.
[http://dx.doi.org/10.2217/nnm-2017-0291] [PMID: 29383985]

Ungaro, F.; d’Angelo, I.; Coletta, C.; d’Emmanuele di Villa Bianca, R.; Sorrentino, R.; Perfetto, B.; Tufano, M.A.; Miro, A.; La Rotonda, M.I.; Quaglia, F. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J. Control. Release, 2012, 157(1), 149-159.
[http://dx.doi.org/10.1016/j.jconrel.2011.08.010] [PMID: 21864595]

Ohashi, K.; Kabasawa, T.; Ozeki, T.; Okada, H. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J. Control. Release, 2009, 135(1), 19-24.
[http://dx.doi.org/10.1016/j.jconrel.2008.11.027] [PMID: 19121349]

Chauhan, N.; Jaggi, M.; Chauhan, S.C.; Yallapu, M.M. COVID-19: Fighting the invisible enemy with microRNA. Expert Rev. Anti Infect. Ther., 2021, 19(2), 137-145.

Mohamed, A.; Kunda, N.K.; Ross, K.; Hutcheon, G.A.; Saleem, I.Y. Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD). Eur. J. Pharm. Biopharm., 2019, 136, 1-8.
[http://dx.doi.org/10.1016/j.ejpb.2019.01.002] [PMID: 30615927]

Sanders, N.; Rudolph, C.; Braeckmans, K.; De Smedt, S.C.; Demeester, J. Extracellular barriers in respiratory gene therapy. Adv. Drug Deliv. Rev., 2009, 61(2), 115-127.
[http://dx.doi.org/10.1016/j.addr.2008.09.011] [PMID: 19146894]

Suk, J.S.; Lai, S.K.; Boylan, N.J.; Dawson, M.R.; Boyle, M.P.; Hanes, J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N -acetyl cysteine. Nanomedicine (Lond.), 2011, 6(2), 365-375.
[http://dx.doi.org/10.2217/nnm.10.123] [PMID: 21385138]

Hadinoto, K.; Sundaresan, A.; Cheow, W.S. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm., 2013, 85(3)(3 Pt A), 427-443.
[http://dx.doi.org/10.1016/j.ejpb.2013.07.002] [PMID: 23872180]

Cheow, W.S.; Chang, M.W.; Hadinoto, K. The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf. A Physicochem. Eng. Asp., 2011, 389(1-3), 158-165.
[http://dx.doi.org/10.1016/j.colsurfa.2011.08.035]

Abbasi, E.; Aval, S.F.; Akbarzadeh, A.; Milani, M.; Nasrabadi, H.T.; Joo, S.W.; Hanifehpour, Y.; Nejati-Koshki, K.; Pashaei-Asl, R. Dendrimers: Synthesis, applications, and properties. Nanoscale Res. Lett., 2014, 9(1), 247.
[http://dx.doi.org/10.1186/1556-276X-9-247] [PMID: 24994950]

Kesharwani, P.; Jain, K.; Jain, N.K. Dendrimer as nanocarrier for drug delivery. Prog. Polym. Sci., 2014, 39(2), 268-307.
[http://dx.doi.org/10.1016/j.progpolymsci.2013.07.005]

Ryan, G.M.; Kaminskas, L.M.; Kelly, B.D.; Owen, D.J.; McIntosh, M.P.; Porter, C.J.H. Pulmonary administration of PEGylated polylysine dendrimers: Absorption from the lung versus retention within the lung is highly size-dependent. Mol. Pharm., 2013, 10(8), 2986-2995.
[http://dx.doi.org/10.1021/mp400091n] [PMID: 23750747]

Rinto, R.; Lestari, S.D.; Baehaki, A.; Sari, Y. The effect of degradation time in the simulated gastric fluid for bioactive compounds from bekasam. IOP Conf. Ser. Earth Environ. Sci., 2020, 404(1), 012018.
[http://dx.doi.org/10.1088/1755-1315/404/1/012018]

Astrup, T.; Crookston, J.; Macintyre, A. Proteolytic enzymes in blood. Acta Physiol. Scand., 1950, 21(2-3), 238-249.
[http://dx.doi.org/10.1111/j.1748-1716.1950.tb00732.x] [PMID: 14856775]

ClinicalTrials.gov. Monovalent recombinant COVID19 vaccine; , 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04453852

Guerrini, G.; Magrì, D.; Gioria, S.; Medaglini, D.; Calzolai, L. Characterization of nanoparticles-based vaccines for COVID-19. Nat. Nanotechnol., 2022, 17(6), 570-576.
[http://dx.doi.org/10.1038/s41565-022-01129-w] [PMID: 35710950]

Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Marc, G.P.; Moreira, E.D.; Zerbini, C.; Bailey, R.; Swanson, K.A.; Roychoudhury, S.; Koury, K.; Li, P.; Kalina, W.V.; Cooper, D.; Frenck, R.W.; Hammitt, L.L.; Türeci, Ö.; Nell, H.; Schaefer, A.; Ünal, S.; Tresnan, D.B.; Mather, S.; Dormitzer, P.R.; Şahin, U.; Jansen, K.U.; Gruber, W.C. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. Engl. N. J. Med., 2020, 383(27), 2603-2615.
[http://dx.doi.org/10.1056/NEJMoa2034577]

Schoenmaker, L.; Witzigmann, D.; Kulkarni, J.A.; Verbeke, R.; Kersten, G.; Jiskoot, W.; Crommelin, D.J.A. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int. J. Pharm., 2021, 601, 120586.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120586] [PMID: 33839230]

Heath, P.T.; Galiza, E.P.; Baxter, D.N.; Boffito, M.; Browne, D.; Burns, F.; Chadwick, D.R.; Clark, R.; Cosgrove, C.; Galloway, J.; Goodman, A.L.; Heer, A.; Higham, A.; Iyengar, S.; Jamal, A.; Jeanes, C.; Kalra, P.A.; Kyriakidou, C.; McAuley, D.F.; Meyrick, A.; Minassian, A.M.; Minton, J.; Moore, P.; Munsoor, I.; Nicholls, H.; Osanlou, O.; Packham, J.; Pretswell, C.H.; Alberto, S.F.R.; Saralaya, D.; Sheridan, R.P.; Smith, R.; Soiza, R.L.; Swift, P.A.; Thomson, E.C.; Turner, J.; Viljoen, M.E.; Albert, G.; Cho, I.; Dubovsky, F.; Glenn, G.; Rivers, J.; Robertson, A.; Smith, K. Toback, Seth Safety and efficacy of NVX-CoV2373 covid-19 vaccine. N. Engl. J. Med., 2021, 385(13), 1172-1183.
[http://dx.doi.org/10.1056/NEJMoa2107659]

Magnusson, S.E.; Altenburg, A.F.; Bengtsson, K.L.; Bosman, F.; de Vries, R.D.; Rimmelzwaan, G.F.; Stertman, L. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunol. Res., 2018, 66(2), 224-233.
[http://dx.doi.org/10.1007/s12026-018-8991-x] [PMID: 29594879]

Dhawan, A.; Sharma, V. Toxicity assessment of nanomaterials: Methods and challenges. Anal. Bioanal. Chem., 2010, 398(2), 589-605.
[http://dx.doi.org/10.1007/s00216-010-3996-x] [PMID: 20652549]

Landen, C.N., Jr; Chavez-Reyes, A.; Bucana, C.; Schmandt, R.; Deavers, M.T.; Lopez-Berestein, G.; Sood, A.K. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res., 2005, 65(15), 6910-6918.
[http://dx.doi.org/10.1158/0008-5472.CAN-05-0530] [PMID: 16061675]

Höbel, S.; Aigner, A. Nonviral delivery platform for therapeutic RNAi: Pegylated siRNA/cationic liposome complexes for targeting of the proto-oncogene bcl-2. Future Oncol., 2009, 5(1), 13-17.
[http://dx.doi.org/10.2217/14796694.5.1.13] [PMID: 19243292]

Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release, 2006, 114(1), 100-109.
[http://dx.doi.org/10.1016/j.jconrel.2006.04.014] [PMID: 16831482]

Barreto, J.A.; O’Malley, W.; Kubeil, M.; Graham, B.; Stephan, H.; Spiccia, L. Nanomaterials: Applications in cancer imaging and therapy. Adv. Mater., 2011, 23(12), H18-H40.
[http://dx.doi.org/10.1002/adma.201100140] [PMID: 21433100]